| Mepha Pharma AG - Fesoterodin-Mepha 4 mg, Retardtabletten | | 68790 | | 01 | | Fesoterodin-Mepha 4 mg | | Retardtabletten | | G04BD11 | | Fesoterodine | | 27.06.2022 | | |
| | Composition | | fesoterodini fumaras 4.0 mg corresp. fesoterodinum 3.1 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 127.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, glyceroli monocaprylocapras, natrii laurilsulfas, E 132, pro compresso obducto, natrium 0.045 mg. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Fesoterodini Fumaras | 4 mg correspond Fesoterodinum 3.1 mg |
| | BAG: Active Agent | Dose |
|---|
| Fesoterodini Fumaras | 4 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Glyceroli Dibehenas | | | | Glyceroli Monocaprylocapras | | | | Hypromellosum | | | | Lactose Monohydrate | 127.125 mg | | | Natrii Laurilsulfas | | | | Sodium | 0.045 mg | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| |
|
